Maven Biotechnologies Gets $1.9M Grant from NIAID | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Maven Biotechnologies announced it has received a $1.96 million grant from the National Institute for Allergy and Infectious Disease to support commercialization of its technology for label-free protein microarrays and cell-based assays.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.